These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 20583295)
1. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function. Piters E; Culha C; Moester M; Van Bezooijen R; Adriaensen D; Mueller T; Weidauer S; Jennes K; de Freitas F; Löwik C; Timmermans JP; Van Hul W; Papapoulos S Hum Mutat; 2010 Jul; 31(7):E1526-43. PubMed ID: 20583295 [TBL] [Abstract][Full Text] [Related]
2. A generalized skeletal hyperostosis in two siblings caused by a novel mutation in the SOST gene. Balemans W; Cleiren E; Siebers U; Horst J; Van Hul W Bone; 2005 Jun; 36(6):943-7. PubMed ID: 15869924 [TBL] [Abstract][Full Text] [Related]
3. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target? Balemans W; Van Hul W J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113 [TBL] [Abstract][Full Text] [Related]
4. Novel SOST gene mutation in a sclerosteosis patient from Morocco: a case report. Belkhribchia MR; Collet C; Laplanche JL; Hassani R Eur J Med Genet; 2014 Mar; 57(4):133-7. PubMed ID: 24594238 [TBL] [Abstract][Full Text] [Related]
5. Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover. van Lierop AH; Hamdy NA; Hamersma H; van Bezooijen RL; Power J; Loveridge N; Papapoulos SE J Bone Miner Res; 2011 Dec; 26(12):2804-11. PubMed ID: 21786318 [TBL] [Abstract][Full Text] [Related]
6. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models. Sebastian A; Loots GG Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811 [TBL] [Abstract][Full Text] [Related]
7. SOST/sclerostin, an osteocyte-derived negative regulator of bone formation. van Bezooijen RL; ten Dijke P; Papapoulos SE; Löwik CW Cytokine Growth Factor Rev; 2005 Jun; 16(3):319-27. PubMed ID: 15869900 [TBL] [Abstract][Full Text] [Related]
8. A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin. Kim CA; Honjo R; Bertola D; Albano L; Oliveira L; Jales S; Siqueira J; Castilho A; Balemans W; Piters E; Jennes K; Van Hul W Genet Test; 2008 Dec; 12(4):475-9. PubMed ID: 19072561 [TBL] [Abstract][Full Text] [Related]
9. A Novel Loss-of-Sclerostin Function Mutation in a First Egyptian Family with Sclerosteosis. Fayez A; Aglan M; Esmaiel N; El Zanaty T; Abdel Kader M; El Ruby M Biomed Res Int; 2015; 2015():517815. PubMed ID: 25984533 [TBL] [Abstract][Full Text] [Related]
10. Novel SOST gene mutation in a sclerosteosis patient and her parents. Bhadada SK; Rastogi A; Steenackers E; Boudin E; Arya A; Dhiman V; Bhansali A; Van Hul W Bone; 2013 Feb; 52(2):707-10. PubMed ID: 23079137 [TBL] [Abstract][Full Text] [Related]
11. Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review. Whyte MP; Deepak Amalnath S; McAlister WH; Pedapati R; Muthupillai V; Duan S; Huskey M; Bijanki VN; Mumm S Bone; 2018 Nov; 116():321-332. PubMed ID: 30077757 [TBL] [Abstract][Full Text] [Related]
12. Sclerosteosis caused by a novel nonsense mutation of SOST in a consanguineous family. He WT; Chen C; Pan C; Zhang MX; Yu XF; Wang DW; Hu SH Clin Genet; 2016 Feb; 89(2):205-9. PubMed ID: 26283468 [TBL] [Abstract][Full Text] [Related]
13. Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. van Bezooijen RL; Svensson JP; Eefting D; Visser A; van der Horst G; Karperien M; Quax PH; Vrieling H; Papapoulos SE; ten Dijke P; Löwik CW J Bone Miner Res; 2007 Jan; 22(1):19-28. PubMed ID: 17032150 [TBL] [Abstract][Full Text] [Related]
14. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone. Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728 [TBL] [Abstract][Full Text] [Related]
15. A Novel Mutation in a Gene Causes Sclerosteosis in a Family of Mediterranean Origin. Ekhzaimy AA; Alyusuf EY; Alswailem M; Alzahrani AS Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208525 [No Abstract] [Full Text] [Related]
16. Bone morphogenetic proteins and their antagonists: the sclerostin paradigm. van Bezooijen RL; Papapoulos SE; Löwik CW J Endocrinol Invest; 2005; 28(8 Suppl):15-7. PubMed ID: 16323824 [TBL] [Abstract][Full Text] [Related]
17. The Lrp4R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans. Boudin E; Yorgan T; Fijalkowski I; Sonntag S; Steenackers E; Hendrickx G; Peeters S; De Maré A; Vervaet B; Verhulst A; Mortier G; D'Haese P; Schinke T; Van Hul W J Bone Miner Res; 2017 Aug; 32(8):1739-1749. PubMed ID: 28477420 [TBL] [Abstract][Full Text] [Related]
18. Sclerostin: a novel target for intervention in the treatment of osteoporosis. Lewiecki EM Discov Med; 2011 Oct; 12(65):263-73. PubMed ID: 22031665 [TBL] [Abstract][Full Text] [Related]
19. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition. Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318 [TBL] [Abstract][Full Text] [Related]
20. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation. Sutherland MK; Geoghegan JC; Yu C; Turcott E; Skonier JE; Winkler DG; Latham JA Bone; 2004 Oct; 35(4):828-35. PubMed ID: 15454089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]